COMMUNIQUÉS West-GlobeNewswire

Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
12/11/2018
Conference Call Scheduled November 12, 2018 at 4:30 p.m. ET BERKELEY HEIGHTS, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Unum Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
12/11/2018
- ACTR707 in Combination with Rituximab Selected as Lead Product Candidate for Further Development in r/r NHL – - New Solid Tumors Technology Platform Revealed at SITC – - More Details on Solid Tumor Activities to be [...]
Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid Tumors
12/11/2018
CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, today announced that [...]
Integra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary
12/11/2018
PLAINSBORO, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Eric Schwartz as corporate vice president, general counsel and secretary. “I [...]
Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.
12/11/2018
Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark MAXKAFLEN Goods and Services IC 005. US 006 018 044 046 051 052. G & S [...]
BioSig Technologies to Ring NASDAQ Opening Bell on November 13, 2018
12/11/2018
Santa Monica, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed [...]
Atrion Corporation Declares Quarterly Cash Dividend
12/11/2018
ALLEN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.35 per share on the Company’s outstanding Common [...]
Sanofi: Disclosure of trading in own shares
12/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
12/11/2018
Pièce jointe Reporting FR.pdf
CFN Media Launches Regular Showcasing of Leading Cannabis Funds & Investment Bankers
12/11/2018
Seattle, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]
Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) Presented during Presidential Plenary Clinical Session of The Liver Meeting® 2018
12/11/2018
-- Statistically significantly more NASH resolution in MGL-3196 as compared with placebo in a Phase 2 clinical trial support MGL-3196 as a first- and potentially best-in class thyroid hormone receptor (THR) β-selective [...]
Managers’ transactions
12/11/2018
BioPorto A/S Managers' Transactions November 12, 2018 Company announcement no. 21 Managers’ transactions BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below [...]
Early close of fully subscribed private placement
12/11/2018
November 12, 2018 Announcement no. 20 Early close of fully subscribed private placement The Board of Directors of BioPorto A/S (BioPorto) decided on November 11, 2018 to partially exercise the authorization in article [...]
MediPharm Labs Corp. Receives Sales Licence from Health Canada
12/11/2018
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“ MediPharm Labs ” or the “ Company ”) (TSXV: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has received its sales [...]
Ossur Hf : Transactions in relation to share buyback program
12/11/2018
Announcement no. 66/2018 12 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Abeona Therapeutics annonce ses résultats financiers et les faits marquants du troisième trimestre 2018
12/11/2018
Conférence téléphonique est organisée pour les investisseurs le lundi 12 novembre à 10h00 ET (16h00 CET) NEW YORK et CLEVELAND, 12 nov. 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), une société [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
12/11/2018
FIT Biotech Oy Company release November 12, 2018 at 5:45 PM EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]
Jefferson and Teladoc Introduce First Telehealth Fellowship
12/11/2018
Academic influencer and market leader in virtual care partner to advance telehealth PURCHASE, NY, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today unveiled a [...]
Physeon Announces Enrollment of First Patient in US “VIVA” Trial for Veinplicity
12/11/2018
Important Milestone for Veinplicity Study SCHAFFHAUSEN, Switzerland, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, [...]

Pages